Abstract. HOX genes encode transcription factors that function to establish basic body pattern during embryogenesis and maintain the function of specific organs in the adult. Recent studies have demonstrated that HOX genes are also involved in oncogenesis in a range of malignancies. To elucidate whether HOX genes contribute to ovarian carcinogenesis, we created an expression profile of HOX genes using ovarian derived materials from surgical samples and epithelial ovarian cancer cells derived from five different cell lines. Real-time quantitative RT-PCR assay indicated overexpression of 14 HOX genes in clusters A and B but only 2 genes in clusters C and D. Of the 16 HOX genes, overexpression of paralogs of HOX3, HOX4 and HOX7 is seen in cluster A and B, and of HOX13 in all paralogs. In addition, HOXB7, HOXA13 and HOXB13 showed high levels of overexpression in cancer cells and tissues whereas no or little expression was observed in normal controls. To examine whether overexpressed HOX genes regulate invasion of ovarian cancer cells directly, we introduced an antisense DNA fragment of overexpressed HOXB7 and HOXB13, and HOXC5 that did not show overexpression into SKOV3 cells by electroporation. Antisense introduction followed by chemoinvasion assay using matrigel chamber demonstrated that SKOV3 cells introduced an antisense of each HOXB7 and HOXB13 showed 85% and 50% reduction of invasion ability compared to the parental SKOV3 cells, respectively. In contrast, antisense of HOXC5 introduced cells showed no significant difference of the invasion ability. These results suggest an important role of overexpressed HOX genes, especially for invasive characteristics of ovarian cancer cells.
Introduction
Epithelial ovarian cancer is a significant female disease with a high rate of mortality, mainly because most patients are diagnosed at advanced clinical stages due to their delay in visiting a hospital and the easy diffusion of cancer cells into pelvic and abdominal cavities (1) . Thus, elucidating the mechanisms of invasion and metastasis in ovarian cancer is essential for understanding the nature of ovarian cancer. In order to invade or metastasize, the cancer cells must move from the ovarian surface lesion, inside or outside of the ovary as a primary site, to secondary metastatic sites. This involves detachment from neighboring cells, transfer of the cells after intravasation, and then proliferation after extravasation. This complicated functional alteration of the cells requires changes in the characteristics of the cells, such as the phenomenon seen in epithelial mesenchymal transition (EMT) regulated by several molecules such as TGF, Ras, Wnt and Snail (2) (3) (4) (5) (6) (7) (8) (9) (10) . In early embryogenesis, these molecules are also utilized to form the basic embryonic body pattern via EMT. HOX genes, encoding homeodomain as DNA-binding domain and consisting of 39 members in four different clusters, are one type of such regulatory transcription molecules that express in the anterior-posterior axis, limbs, and genital buds during mammalian embryogenesis. Published studies suggest that HOX genes provide intercellular information for the determination of identity, lineage and fate of the cells (11, 12) .
Interestingly, recent reports have provided evidence that the abnormal expression of certain HOX genes is observed in a variety of malignancies such as hematologic, breast, colon, prostate, bladder, lung, and thyroid cancer (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . In the gynecologic field, there are several reports describing that abnormal expression of particular HOX genes seems to be involved in cervical, ovarian and endometrial neoplasms (23) (24) (25) (26) including a recent report by Zhao et al (27) . In the context of embryonic development, the expression of invasive characteristics of cancer cells might be a similar phenomenon, analogous to the movement of normal embryonic cells mediated by expression of HOX genes. This leads to a possibility that overexpression of certain HOX genes in ovarian cancer cells could accelerate invasion of the cancer cells.
In this study, we first created an expression profile of HOX genes in ovarian-derived samples to investigate whether Table I . Primer sequences of 36 HOX genes for real-time PCR. 
Primer sequences were obtained from Vider et al (28, 30) , Alami et al (29) and nucleotide sequence database. NCBI accession numbers of HOXA, HOXB, HOXC and HOXD are NT_007819, NT_086883, NT_086796 and NT_005403, respectively.
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cancer cells show overexpression of HOX genes in ovarian cancer cells. Then, we examined the invasion ability of the cells introduced with an antisense of two overexpressed HOX genes by invasion assay to evaluate whether introduction of the antisense leads to suppression of the invasion ability of cancer cells.
Materials and methods

Isolation of total RNA from cells and tissues.
Five epithelial ovarian cancer cell lines ES-2, SKOV3, CAOV3 (from ATCC), SMOV2 (gifted by Dr K. Yonamine) and JHOC-6 (gifted by Dr H. Ishikawa), were used in this study. These cells were cultured under the supplier's recommendations. At 80% confluence, the cells were harvested and served in isolation of total RNA. As sources of normal and ovarian cancer tissues, surgical specimens were obtained from women who had undergone gynecological surgery due to benign uterine diseases and ovarian cancer in Asahikawa Medical College Hospital; all had agreed to provide specimens for the study approved by the Ethics Committee of the Asahikawa Medical College. Diagnosis of normal ovarian tissues in all patients was finally confirmed by histopathological examination. Total RNA from these samples was isolated with RNeasy™ (Qiagen Inc., USA) after homogenization of the samples. Isolated total RNA (1 μg) treated with DNaseI was reversetranscribed into cDNA by Reverse Transcription system™ (Promega Inc., USA), then subjected to real-time polymerasechain reaction (real-time RT-PCR) using SmartCycler™ (Cepheid, USA).
Quantitative real-time RT-PCR of ovarian derived samples.
Quantitative real-time RT-PCR was applied using gene specific primer sets for the HOX genes (Table I) . To adjust the concentrations of reverse-transcribed cDNA from mRNA in each sample, ß-actin was used as an internal control. Each 25 μl of PCR mixture contained 0.3 μM of sense and antisense primers, 1 μl of cDNA solution, 12.5 μl of PCR premixture (Quantiteck SYBR Green PCR Kit™, Qiagen Inc.) and 6.5 μl of supplied water. Typical PCR was performed using first cycle at 95˚C for 15 min to activate HotStar Taq polymerase in the premixture, followed by 45 cycles of 94˚C for 30 sec, 55˚C for 30 sec, and 72˚C for 30 sec, respectively. Prior to measurement of the gene product by real-time RT-PCR, production of the single target band of each HOX gene was confirmed by electrophoresis using Bioanalyser 2100 (Agilent, USA). Then standard DNA solutions were produced by serial dilutions of columnpurified PCR products (PCR Purification kit, Qiagen Inc.) showing the target band for relative quantitative analysis of HOX and ß-actin expressions. The original PCR products containing 5-50 ng/μl of target HOX and ß-actin fragments were diluted into 10 -5 , 10 -7 , 10 -8 , 10 -9 and 10 -10 with distilled water mixed salmon DNA for establishment of standard curves. The signal intensity in the real-time RT-PCR was measured at 5˚C lower than melting temperature of each product for each cycle. Relative quantity of each HOX sample was adjusted by ratio of expression of the ß-actin (HOX/ ß-actin) and the degree of expression among each sample was evaluated based on the comparison with the expression of simultaneous-amplified standard solutions. For judgment of overexpression of HOX gene in cancer cells, the average expression level of three normal samples in each HOX gene was calculated; the expression level of HOX gene in each cancer cell line was then compared with the normal average. Degree of overexpression in the cancer cells is shown numerically or with arrows in cases where the expression in the normal samples was not detected.
Antisense gene introduction of overexpressed HOX genes by electroporation. Sequence of antisense fragments of HOXB7, HOXB13 and HOXC5 as control was designed by sequences from a database (NCBI, Entrez Nucleotide). At first, each antisense fragment was generated by PCR with gene specific primer sets (HOXB7 sense 5'-cattgattatgcgaatgcttt-3', antisense 5'-cgcagtgcatgttgaaggaact-3'; HOXB13 sense 5'-tacgct gatgcctgctgtcaacta-3', antisense 5'-cacaggcaacagggagtcatg tcg-3'; HOXC5 sense 5'-aggtgcaggcatccaggtactg-3', antisense 5'-aggcatccaggtactgctacgg-3'), and then the products were introduced into pGEM-Teasy™ vector (Invirogen, USA). The sequence of PCR products introduced to the vector was confirmed by DNA sequencer (SEQ4X4 personal sequencing system, Amersham Pharmacia Biotech). The vector was digested with ERI, and fragments were released to be reintroduced into another vector pcDNA3.1 (Invirogen), containing Neo-r gene for selection. The vector (50 μg) containing each antisense fragment was lineralized by ApaI and used for electroporation with 2.6x10 6 of SKOV3 cells (Gene Pulser, Bio-Rad). The condition of electroporation was as follows: cuvette gap, 0.4 cm; voltage, 0.25 kV; capacitor, 500 μF. After electroporation, treated cells were cultured for 24 h prior to use of G418 for selection of the antisenseintroduced cells. Culture with G418 was continued for 5 days; then RT-PCR with isolated total RNA from the cultured cells was carried out to check introduction and expression of the target antisense fragment using primer sets containing sequences of Neo-r and vector itself. Three independent cell lines introduced with each antisense of HOXB7, HOXB13 and HOXC5 were established for the subsequent invasion assay. Simultaneously, mock SKOV3 cell line (introduction of vector sequence only) was also established.
Matrigel assay for the invasion of the cancer cells.
To examine the manner of invasion among three cells types, parental SKOV3 cell, mock SKOV3 (no antisense fragment) and antisense-introduced SKOV3, matrigel assay was applied as invasion assay. Cells adjusted to 5x10 4 were put on the membrane of the matrigel chamber (Paragon, USA) and cultured for up to 16 h after addition of fibronectin as a chemoattractant. After cultivation, the cells moving through matrigel were microscopically counted using 0.1% trypan blue stain. The ability of invasion of each cell type was calculated as % invasion and an invasion index was calculated.
Results
Overexpressed HOX genes in ovarian cancer cells. In this study, we were able to obtain successful amplification for evaluation in 36 out of 39 HOX genes. In HOXB1, HOXC3 and HOXC9, it is difficult to assess ovarian carcinogenesis because expression of these genes was not observed in either normal or cancer samples, implying the possibility of loss of expression or technical deficiency. In 16 HOX genes, expression in cancer cells was over twice that in normal samples (Table II) . HOXA10, HOXA13, HOXB4, HOXB7, HOXB13 and HOXC13 showed little or no expression in normal samples. In the other genes, there was no significant difference of expression level among the three normal controls (data not shown). In HOXA cluster, there are 11 HOX genes, from HOXA1 to HOXA13. Overexpression in cancer cells was seen to various degrees and in various cell lines in HOXA3, HOXA4, HOXA7, HOXA10 and   HOXA13 . High levels of overexpression were observed in HOXA10 and HOXA13 in all cells except for HOXA10 of SMOV2. The HOXB cluster consists of 10 genes, overexpression was observed in all HOXB examined in this study. In HOXB2, HOXB3, HOXB5, HOXB6 and HOXB8 , overexpression was revealed in only one or two cell lines, SKOV3 with JHOC-6 or ES-2. However, in HOXB4, HOXB7, HOXB9 and HOXB13, multiple cell lines showed high levels of overexpression (Table II and Fig. 1 ). In the HOX C and D clusters, only 2 genes, HOXC13 and HOXD13, showed low levels of overexpression that was detected in HOXC13 of CAOV3 and in HOXD13 of SKOV3. Some data suggested loss or reduction of HOX Table II . Overexpression of HOX genes in the ovarian cancer cell lines by real-time RT-PCR. Paralog no.  1  2  3  4  5  6  7  8  9  10  11  12  13 - 
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The numbers indicate folds of expression level of each HOX gene in cancer cells compared with that in normal samples. expression in cancer cells; however, loss of function was not assessed in this study because pure ovarian surface epithelium from normal controls was not collected. (Fig. 2) . The successful introduction of HOXB7 and HOXB13 antisense fragments by electroporation resulted in the establishment of 3 independent cell lines, P1, P2 and P3 (Fig. 3) . In the same way, antisense of HOXC5 that did not show overexpression was also introduced into 0.85 (85%) and 0.5 (50%) reduction of invasion ability in HOXB7 and HOXB13 respectively, whereas no difference of invasion index (0.75-0.9) between the parental and mock cells of each HOX gene was shown (Table III) .
Discussion
Recent studies have reported that abnormal HOX expression is involved in a wide variety of human diseases, from metabolic disease to cancer, with regard to different aspects including cell-cycle regulation, cell proliferation, angiogenesis, and invasion or metastasis (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . For instance, HOXB4 is involved in stem cell regulation in hematologic cells (42, 43) , while HOXB7 has a role in angiogenesis (31) . HOXA10 is associated with the female reproductive system in the response to sex steroids (44, 45) and invasion of breast cancer cells by regulation of p53 (37) . Mutation of HOXA13 is the cause of the rare inherited disease, hand-food-genital syndrome (46) . HOXB13, has been shown to be involved in differentiation of the epidermal tissue and wound healing (47, 48) , and has been reported to be important for prostate development (49) . These data show the multiple roles of the HOX gene in various stages of human development. Thus, it is highly possible that the role of HOX gene may not be a singular role in ovarian carcinogenesis. We speculated that one of the roles of the HOX gene might be to have the ability of invasion of cancer cells from the viewpoint of regulation of cell movement in embryogenesis.
HOX genes function as a regulatory factor to establish the embryonic body. The female reproductive duct and ovarian surface epithelium are cells formed from the mesodermal layer that are derived from epiblast (ectoderm) through the process of EMT. It is well recognized that fallopian tube, endometrium, cervix and a part of vagina are formed from the Müllerian duct. In contrast, the origin of ovarian surface epithelium is not strictly determined, thus the origin of precursor lesion of ovarian cancer is also undetermined. In a striking paper reported by Cheng et al a possible involvement of histopathological subtypes of ovarian cancer and atypical Table III . The percent of invasion and invasion index by antisense introduced cells. 
Mean no. of cells invading through MG insert membrane
Mean no. of cells invading through control insert membrane % invasion of PV or PI, P3, P6
expression of HOX genes was demonstrated (50) . However, contribution of HOX genes may not be a single factor in ovarian carcinogenesis like the phenomenon seen in embryogenesis. This is the first report providing an expression profile of various HOX genes and direct evidence of the overexpressed HOX genes for the invasion ability of ovarian cancer cells. Of 16 HOX genes overexpressed, HOXA10, HOXA13,  HOXB4, HOXB7 and HOXB13 showed high levels of overexpression in almost all cancer cells and some in tissues, whereas they were undetectable or had very low expression in normal ovarian tissue, strongly suggesting the potential importance and common roles of those genes in the development of ovarian cancer. In particular, abnormal expression of HOXB7 has been demonstrated to involve immortalization of the cells derived from ovarian tissue by Naora et al (24) , indicating substantial roles of HOXB7 in ovarian neoplasm.
To elucidate whether overexpressed HOX genes directly affect the invasion ability of ovarian cancer cells, we introduced an antisense fragment of two highly overexpressed HOX genes, HOXB7 and HOXB13. The HOXB7 was selected because it has been reported to contribute to ovarian neoplasms (24), while we have also found HOXB13 overexpression in endometrial cancer (data not shown) (27) . A marked reduction of invasion ability was seen in HOXB7 (85%) and HOXB13 (50%). By contrast, mock cells introduced to an antisense of HOXB7 or HOXB13, and cells introduced to HOXC5 did not show obvious difference in invasion ability. Taken together, overexpressed HOX genes are directly involved in the invasion ability of the ovarian cancer cells. However, in neither experiment did the invasion index drop to 0% indicating complete suppression. These results suggest that the function of the HOX genes for invasion may be redundant and complemented by other paralogous genes or the genes in the same cluster as the function seen in the embryogenesis. In fact, overexpression of the HOXA7 and HOXA13 that are paralogous genes of HOXB7 and HOXB13, were also observed in this experiment.
It is not clear yet how overexpression of these HOX genes contributes to invasive characteristics of ovarian cancer cells. Investigation to find correlation between abnormal HOX expression and the function of other related genes that mediate cell adhesion such as MMPs, ETS, uPA, PAI, ß-catenin, Ecadherin and Snail, are now under way. However, it is possible to associate HOXB7 and HOXB13 with neovascularization of the cancer tissue that is important to invasion. HOXB13 may function as a gene for wound healing of the damaged portions of the ovarian and endometrial epithelium due to monthly ovulation and menstruation, while HOXB7 supports angiogenesis of the ovarian neoplasms.
